893 related articles for article (PubMed ID: 3698023)
1. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
Lu LJ; Disher RM; Reddy MV; Randerath K
Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
[TBL] [Abstract][Full Text] [Related]
2. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
3. Differences in the covalent binding of benzo[a]pyrene, safrole, 1'-hydroxysafrole, and 4-aminobiphenyl to DNA of pregnant and non-pregnant mice.
Lu LJ; Disher RM; Randerath K
Cancer Lett; 1986 Apr; 31(1):43-52. PubMed ID: 3697953
[TBL] [Abstract][Full Text] [Related]
4. A comparison of DNA adduct formation in white blood cells and internal organs of mice exposed to benzo[a]pyrene, dibenzo[c,g]carbazole, safrole and cigarette smoke condensate.
Reddy MV; Randerath K
Mutat Res; 1990 May; 241(1):37-48. PubMed ID: 2333084
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of gestation stage on benzo(a)pyrene-induced micronucleus formation and/or covalent DNA modifications in mice.
Wang MY; Lu LJ
Cancer Res; 1990 Apr; 50(7):2146-51. PubMed ID: 2317806
[TBL] [Abstract][Full Text] [Related]
6. Effects of route of administration on tissue distribution of DNA adducts in mice: comparison of 7H-dibenzo(c,g)carbazole, benzo(a)pyrene, and 2-acetylaminofluorene.
Schurdak ME; Randerath K
Cancer Res; 1989 May; 49(10):2633-8. PubMed ID: 2713847
[TBL] [Abstract][Full Text] [Related]
7. Induction of covalent DNA modifications and micronucleated erythrocytes by 4-nitroquinoline 1-oxide in adult and fetal mice.
Lu LJ; Baxter JR; Wang MY; Harper BL; Tasaka F; Kohda K
Cancer Res; 1990 Oct; 50(19):6192-8. PubMed ID: 2119250
[TBL] [Abstract][Full Text] [Related]
8. DNA adduct formation in mouse tissues in relation to serum levels of benzo(a)pyrene-diol-epoxide after injection of benzo(a)pyrene or the diol-epoxide.
Ginsberg GL; Atherholt TB
Cancer Res; 1990 Feb; 50(4):1189-94. PubMed ID: 2105163
[TBL] [Abstract][Full Text] [Related]
9. Persistence, gestation stage-dependent formation and interrelationship of benzo[a]pyrene-induced DNA adducts in mothers, placentae and fetuses of Erythrocebus patas monkeys.
Lu LJ; Anderson LM; Jones AB; Moskal TJ; Salazar JJ; Hokanson JA; Rice JM
Carcinogenesis; 1993 Sep; 14(9):1805-13. PubMed ID: 8403203
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
[TBL] [Abstract][Full Text] [Related]
11. Benzo[a]pyrene-7,8-quinone-3'-mononucleotide adduct standards for 32P postlabeling analyses: detection of benzo[a]pyrene-7,8-quinone-calf thymus DNA adducts.
Balu N; Padgett WT; Nelson GB; Lambert GR; Ross JA; Nesnow S
Anal Biochem; 2006 Aug; 355(2):213-23. PubMed ID: 16797471
[TBL] [Abstract][Full Text] [Related]
12. Age-, tissue-, and Ah genotype-dependent differences in the binding of 3-methylcholanthrene and its metabolite(s) to mouse DNA.
Lu LJ; Harvey RG; Lee H; Baxter JR; Anderson LM
Cancer Res; 1990 Jul; 50(14):4239-47. PubMed ID: 2364382
[TBL] [Abstract][Full Text] [Related]
13. Lipid peroxidation-induced putative malondialdehyde-DNA adducts in human breast tissues.
Wang M; Dhingra K; Hittelman WN; Liehr JG; de Andrade M; Li D
Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):705-10. PubMed ID: 8877062
[TBL] [Abstract][Full Text] [Related]
14. Ethylnitrosourea-induced transplacental carcinogenesis in the mouse: tumor response, DNA binding, and adduct formation.
Branstetter DG; Stoner GD; Schut HA; Senitzer D; Conran PB; Goldblatt PJ
Cancer Res; 1987 Jan; 47(2):348-52. PubMed ID: 3791225
[TBL] [Abstract][Full Text] [Related]
15. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
Kulkarni MS; Anderson MW
Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
[TBL] [Abstract][Full Text] [Related]
16. Identification of optimal conditions for the detection of benzo[a]pyrene-DNA adducts by enzyme-linked immunoadsorbent assays (ELISA).
Bucci F; Galati R; Zito R; Falasca G; Federico A; Verdina A
Anticancer Res; 1998; 18(4A):2669-74. PubMed ID: 9703926
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro and in vivo benzo[a]pyrene-DNA adduct formation and its relationship to CYP1A activity in two species of ictalurid catfish.
Ploch SA; King LC; Kohan MJ; Di Giulio RT
Toxicol Appl Pharmacol; 1998 Mar; 149(1):90-8. PubMed ID: 9512731
[TBL] [Abstract][Full Text] [Related]
18. Effects of specific humoral immunity on DNA-adduct formation in Swiss mice treated with benzo[alpha]pyrene.
Galati R; Falasca G; Verdina A
Anticancer Res; 1999; 19(3A):2101-4. PubMed ID: 10470155
[TBL] [Abstract][Full Text] [Related]
19. DNA adducts detected by synchronous fluorescence spectrophotometry in rat liver, kidney, lung and spleen after intraperitoneal administration of benzo[a]pyrene.
Baer-Dubowska W; Kulińska A; Jarmuz M; Brauze D; Gnojkowski J
Acta Biochim Pol; 1993; 40(1):63-5. PubMed ID: 8372569
[No Abstract] [Full Text] [Related]
20. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
